Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
BMC Neurology
|
November 23, 2016
Temporal profile of body temperature in acute ischemic stroke: relation to infarct size and outcome
Marjolein Geurts, Féline E V Scheijmans, Tom van Seeters, et al.
Muscle & Nerve
|
June 27, 2019
Warming nerves for excitability testing
Maria O Kovalchuk, Hessel Franssen, Féline E V Scheijmans, et al.
Plos One
|
January 8, 2025
Views and opinions of the general public about the reimbursement of expensive medicines in the Netherlands
Féline E V Scheijmans, Roosmarijn van der Wal, Margot L Zomers, et al.
BMC Health Services Research
|
November 5, 2022
The reimbursement for expensive medicines: stakeholder perspectives on the SMA medicine nusinersen and the Dutch Coverage Lock policy
Féline E V Scheijmans, Margot L Zomers, Sina Fadaei, et al.
Neurocritical Care
|
October 6, 2021
Deferred Consent in an Acute Stroke Trial from a Patient, Proxy, and Physician Perspective: A Cross-Sectional Survey
Inez Koopman, Dagmar Verbaan, W Peter Vandertop, et al.
Brain Communications
|
November 16, 2022
Population-based assessment of nusinersen efficacy in children with spinal muscular atrophy: a 3-year follow-up study
Féline E V Scheijmans, Inge Cuppen, Ruben P A van Eijk, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
BMC Neurology
|
November 23, 2016
Temporal profile of body temperature in acute ischemic stroke: relation to infarct size and outcome
Marjolein Geurts, Féline E V Scheijmans, Tom van Seeters, et al.
Muscle & Nerve
|
June 27, 2019
Warming nerves for excitability testing
Maria O Kovalchuk, Hessel Franssen, Féline E V Scheijmans, et al.
Plos One
|
January 8, 2025
Views and opinions of the general public about the reimbursement of expensive medicines in the Netherlands
Féline E V Scheijmans, Roosmarijn van der Wal, Margot L Zomers, et al.
BMC Health Services Research
|
November 5, 2022
The reimbursement for expensive medicines: stakeholder perspectives on the SMA medicine nusinersen and the Dutch Coverage Lock policy
Féline E V Scheijmans, Margot L Zomers, Sina Fadaei, et al.
Neurocritical Care
|
October 6, 2021
Deferred Consent in an Acute Stroke Trial from a Patient, Proxy, and Physician Perspective: A Cross-Sectional Survey
Inez Koopman, Dagmar Verbaan, W Peter Vandertop, et al.
Brain Communications
|
November 16, 2022
Population-based assessment of nusinersen efficacy in children with spinal muscular atrophy: a 3-year follow-up study
Féline E V Scheijmans, Inge Cuppen, Ruben P A van Eijk, et al.
Page
of 1